ICLC

The ICLC mission is to improve outcomes and quality of life for patients with low-grade serous ovarian cancer through clinical and scientific collaboration.

[BowtellLab @BowtellLab]

@BowtellLab’s Prof David Bowtell and Dr Rachel Delahunty will be joining @ocrfaustralia on May 8. Register via link below to hear the latest …

[National Ovarian Cancer Coalition @NOCCNational]

Join us in making a difference on May 8th, World Ovarian Cancer Day, and beyond. Help us raise awareness by downloading the social media toolkit and using the hashtag #ShineOnOvarian. https://t.co/VZOwwtrFUC
#WOCD2024 #WorldOvarianCancerDay

[Comphies Graphic Tees @ComphiesTees]

Global Patient Survey Results Reveal Significant Negative Impact on Social, Emotional and Mental Well-Being for People Living with Low-Grade Serous Ovarian Cancer https://t.co/ES3nprP374

[OncLive.com @OncLive]

The combination of avutometinib and defactinib elicited preliminary efficacy signals in the phase 2 RAMP 201 trial, leading to the further evaluation of the combination in low-grade serous ovarian cancer. @sitemancenter #ovca #gyncsm https://t.co/5CTWyIxjHs

[ICLC @ICLCResearch]

@elsalarsen 👏🏻👏🏻👏🏻

[OncLive.com @OncLive]

Avutometinib Plus Defactinib Makes a Phase 3 Debut in Low-Grade Serous Ovarian Cancer @sitemancenter #gyncsm
https://t.co/5CTWyIxjHs

[Ovarcome @ovarcome]

Ovarcoming with Sarah 🩵
Thank you for radiating HOPE and sharing the 5 KEY B.E.A.C.H. symptoms of ovarian cancer (back of t-shirt):
B=Bloating
E=Early Satiety
A=Abdominal &/or Pelvic Pain
C=Changes in Bowel/Bladder Habits
H=Heightened Fatigue
THIS is how #WeOvarcome! 🩵

[Ovarian Cancer Research Alliance @ocrahope]

OCRA Heroes make a difference in the fight against #ovariancancer by raising awareness & critical funds for our research, advocacy & patient support programs. We applaud them for turning their passion into purpose. Learn how you can be an OCRA Hero, too: https://t.co/yrZXTxcnTY

[CrozrX @CrozrX]

Low grade serous ovarian cancer #LGSOC
@threadreaderapp #unroll #TopUnroll
🔻
https://t.co/JOOgsw88NW

[ANZGOG @anzgog]

Next up we have the wonderful Heather Cunliffe, taking us through molecular insights into Low Grade Serous Ovarian Cancer @HeatherCunliffe #LGSOC

[ANZGOG @anzgog]

Integrated multidimensional molecular analysis required to better understand LGSOC #ICLC

[ANZGOG @anzgog]

A wonderful and informative presentation by Dr Isabelle Ray-Coquard on strategies to improve outcomes in rare ovarian tumours. Highlighting the need for collaborative research to answer the unanswered questions in these rare tumours. #ANZGOG2024ASM @anzgog

[Ovarian Cancer Research Alliance @ocrahope]

Please urge your U.S. Representatives to sign on to the Dear Colleague letter urging $50M in funding for the Ovarian Cancer Research Program (OCRP) for Fiscal Year 2025. The OCRP is the only federal research program dedicated to #ovariancancer. Act now: https://t.co/5rwKp1SCYv.

[Ovarcome @ovarcome]

Thank You! 🙏 #Ovarcome

[Ovarcome @ovarcome]

#98! 🎉✨Join us this Thursday, 4/25 at 12:30 PM CST as we Connect Ovar Coffee☕️ with Dr. Premal Thaker to Talk About Understanding & Navigating Clinical Trials in Ovarcoming Ovarian Cancer.
Subscribe. Watch. Learn. Let's #ConnectOvarCoffee!

[ANZGOG @anzgog]

Our wonderful international speakers 🙏 thank you all for sharing your world-leading insight to delegates #ANZGOG2024ASM

[ICLC @ICLCResearch]

@anzgog @annapoids Congratulations!!!

[ANZGOG @anzgog]

This award acknowledges innovative research that has made a difference in gynaecological cancer. Congratulations to Prof Anna DeFazio AM - fully deserved.

Research Pioneer Award 🏆
Winner: @annapoids

#ANZGOG2024ASM

[Elsa Larsen @elsalarsen]

5 members of the @ICLCResearch team on one continent! 🌏👗🩵 @annapoids @HeatherCunliffe @CoquardRay @Cure_Ovarian_Ca @anzgog #ANZGOGASM2024 #LGSOC

[Elsa Larsen @elsalarsen]

Speaking about #SurvivorsTeachingStudents at the Consumer Education Workshop at the #ANZGOGASM2024 @anzgog #ovariancancer